Expert Recommendations on the Use of Hyaluronic Acid Filler for Tear Trough Rejuvenation

J Drugs Dermatol. 2022 Apr 1;21(4):387-392. doi: 10.36849/JDD.6597.

Abstract

Restylane® Lidocaine is one of the most widely used hyaluronic acid (HA) fillers to replace lost or displaced volume during tear trough correction. Patient goals for tear trough correction include looking less tired or removing dark circles and this may be achieved by administering HA filler into the infraorbital region to correct the lower eyelid relative to the volume deficit, thereby smoothing the transition from the lower eyelid to the cheek. To achieve patient satisfaction and consistent results with Restylane, optimal application is essential; however, clinical guidance based on experience is limited. This paper reflects the recommendations of an interdisciplinary expert panel for the use of Restylane in correcting tear trough deformity, including patient selection, dosing, injection technique, and post-treatment care. Recommendations were discussed and agreed as a consensus, according to cross-sectional expertise and clinical experience. J Drugs Dermatol. 2022;21(4):387-392. doi:10.36849/JDD.6597.

MeSH terms

  • Cosmetic Techniques*
  • Cross-Sectional Studies
  • Dermal Fillers* / adverse effects
  • Eyelids
  • Humans
  • Hyaluronic Acid / adverse effects
  • Rejuvenation
  • Skin Aging*

Substances

  • Dermal Fillers
  • Hyaluronic Acid